Gene: FRAT1
Official Full Name: FRAT regulator of WNT signaling pathway 1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the GSK-3-binding protein family. The protein inhibits GSK-3-mediated phosphorylation of beta-catenin and positively regulates the Wnt signaling pathway. It may function in tumor progression and in lymphomagenesis. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11785 | FRAT1 Knockout cell line (HeLa) | Human | FRAT1 | 1:3~1:6 | Negative | Online Inquiry |
KO11786 | FRAT1 Knockout cell line (HEK293) | Human | FRAT1 | 1:3~1:6 | Negative | Online Inquiry |
FRAT1 Gene Knockout Cell Lines are genetically engineered cell lines in which the FRAT1 gene—the gene associated with the regulation of the Wnt signaling pathway—has been selectively disrupted. This targeted gene knockout allows researchers to investigate the functional roles of FRAT1 in various biological processes, including cell proliferation, differentiation, and tumorigenesis. By eliminating the expression of this gene, scientists can create models to examine the downstream effects on Wnt signaling, which is critically implicated in numerous developmental and disease states.
These cell lines function by utilizing CRISPR/Cas9 gene-editing technology, providing a convenient and efficient method for precise genome editing. This allows for the creation of a reliable platform to study the impact of FRAT1 loss on cellular behaviors in vitro. Researchers can employ these knockout cell lines in functional assays, signaling pathway analyses, and drug sensitivity tests, thus expanding the scope of their experimental inquiries.
The scientific importance of FRAT1 Gene Knockout Cell Lines cannot be overstated as they offer invaluable insights into the etiology of various cancers and developmental disorders linked to aberrant Wnt signaling. In clinical settings, understanding FRAT1’s role could pave the way for novel therapeutic strategies aimed at diseases driven by aberrant cellular signaling.
Compared to traditional gene silencing methods like siRNA, the FRAT1 Gene Knockout Cell Lines deliver permanent gene disruption, making them a more robust choice for long-term studies. Furthermore, these cell lines can be readily characterized and validated, ensuring reproducible results that are essential in rigorous scientific investigations.
For researchers and clinicians seeking to explore the complexities of cellular signaling pathways, the FRAT1 Gene Knockout Cell Lines stand out as a versatile tool, enhancing their ability to unravel the genetic underpinnings of health and disease. Backed by our company’s extensive expertise in genetic engineering and commitment to providing high-quality biological products, we are dedicated to equipping scientists with innovative solutions to advance their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.